Applied Statistics
Pharmaceutical Collaboration, Licensing and Acquisition Strategies: From Drug to Drug-Device Combinations
Sheraton Philidelphia City Center Hotel

Philadelphia, Pennsylvania


   A top challenge with those involved in executing alliance and partner
   deals is having a seat at the table during the due diligence process
   and original negotiations. This conference will focus on the steps and
   decisions involved before the deal is signed. Themes covered include
   new frontiers in biomarker and drug development; how alliances are
   working across the industry; decision drivers for aligning or not
   aligning; being recognized as a partner of choice, and shared
   ‘learnings’ from different alliance and partnering models including
   medical devices, licensing, and mergers & acquisitions.

Schedule of Presentations:

Sunday, April 11, 2010
Monday, April 12, 2010
Tuesday, April 13, 2010
Wednesday, April 14, 2010
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.